MiniMed Group Plans Nasdaq Debut to Advance Diabetes Care Technology
MiniMed Group has submitted a filing for an initial public offering on Nasdaq to further its mission of improving diabetes care worldwide. With over four decades of history, the company offers a comprehensive, integrated system designed to enhance clinical outcomes and patient experience through advanced diabetes management.